A health wine for improving sleep function
By combining traditional Chinese medicinal herbs with baijiu (Chinese liquor) in a specific ratio, a health-promoting liquor for improving sleep has been prepared. This solves the problems of side effects of Western medicine and unclear efficacy of existing health-promoting liquors, achieving the effect of improving sleep and market promotion value.
Patent Information
- Application Number
- CN202111397900.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2021-11-19
- Publication Date
- 2024-11-26
- Estimated Expiration
- 2041-11-19
AI Technical Summary
Existing treatments for insomnia include Chinese and Western medicines with significant side effects, and existing health tonics have complex flavors, unclear efficacy, and lack scientific formulas and simple preparation processes.
By combining traditional Chinese medicinal herbs such as Schisandra chinensis, Ganoderma lucidum, Poria cocos, and Ophiopogon japonicus with baijiu (Chinese liquor), and through specific soaking and flavoring ratios, a health-promoting wine for improving sleep is prepared. The process includes soaking, filtering, and aging to ensure high content of active ingredients and a mellow and fragrant taste.
It has achieved significant sleep improvement, has a high content of active ingredients, a pleasant taste, and significant market potential.
Smart Images

Figure CN116144446B_ABST
Abstract
Description
Technical Field
[0001] The invention specifically relates to a health wine for improving sleep function. Background Art
[0002] Insomnia patients often have difficulty falling asleep, poor sleep quality, and a total sleep time of less than 6 hours. Chinese medicine calls this "insomnia". Insomnia can cause a person's body immunity to decline, weakening resistance to various diseases. It can also cause autonomic dysfunction, lack of concentration, decreased thinking ability, depression, anxiety, mental tension and other emotions, cerebral cortex dysfunction, autonomic dysfunction, and severe cases of mental illness and neurosis.
[0003] At present, the treatment of insomnia is mainly based on Western medicine, but Western medicine has obvious side effects. For example, long-term use of benzodiazepines can cause dependence, withdrawal symptoms, addiction and other disadvantages. There are also daily diet therapy to improve sleep. For example, patent CN202110520404.3 discloses a health wine for improving sleep, but it has problems such as complex taste, unclear effective ingredients, and unclear effect on improving sleep. Therefore, it is necessary to research and develop a health wine for improving sleep with scientific and reasonable formula, simple preparation process, easy mass production, clear material basis of efficacy, and definite effect on improving sleep. Summary of the invention
[0004] In order to solve the above problems, the present invention provides a health wine for improving sleep function, which is prepared from raw materials containing the following proportions:
[0005] 8-20 parts by weight of Schisandra chinensis, 8-20 parts by weight of Ganoderma lucidum, 6-18 parts by weight of Poria cocos, 5-12 parts by weight of Ophiopogon japonicus, and 800-1200 parts by volume of liquor.
[0006] Furthermore, it is prepared from raw materials containing the following proportions:
[0007] 15 parts of Schisandrae Chinensis Fruit, 15 parts of Ganoderma Lucidum, 12 parts of Poria, 6 parts of Ophiopogon japonicus, and 1000 parts by volume of liquor.
[0008] Furthermore, the raw material also contains 1 to 5 parts of longan pulp, 1 to 3 parts of liquorice and / or 1 to 3 parts of monk fruit.
[0009] Furthermore, it is prepared from raw materials containing the following proportions:
[0010] 15 parts of Schisandrae Chinensis Fruit, 15 parts of Ganoderma Lucidum, 12 parts of Poria, 6 parts of Ophiopogon, 3 parts of Longan Meat, 2 parts of Licorice, 2 parts of Momordica grosvenori, and 1000 parts by volume of white wine.
[0011] Furthermore, the alcohol content of the liquor is 30-60%, preferably 40%.
[0012] The present invention also provides a method for preparing the aforementioned health wine, which comprises the following steps:
[0013] Take sliced Ganoderma lucidum, crushed Schisandra chinensis, Poria cocos and Ophiopogon japonicus, mix them, add white wine and soak them twice. The amount of white wine used twice is 12 to 15 times (v / w, ml / g) and 8 to 11 times (v / w, ml / g) of the raw materials respectively. Soak for 7 to 15 days each time. Circulate the soaking liquid during the soaking period. Filter after the soaking is completed, combine the filtrate, add the remaining amount of white wine, let it stand at 15 to 30°C for more than 1 month, and then filter to obtain the product.
[0014] The present invention finally provides a method for preparing the aforementioned health wine, which comprises the following steps:
[0015] a. Take sliced Ganoderma lucidum, crushed Schisandra chinensis, Poria cocos and Radix Ophiopogonis, mix them, soak them twice with liquor, the amount of liquor used twice is 12 to 15 times the amount v / w, ml / g, and 8 to 11 times the amount v / w, ml / g of the raw materials respectively, the soaking time is 7 to 15 days, the soaking liquid is circulated during the soaking period, and after the soaking, the filtrate is combined to obtain the sleep compound extraction stock solution;
[0016] b. Take longan pulp, licorice and monk fruit respectively, soak them in 12 to 15 times the amount of raw materials v / w, ml / g of liquor, filter and obtain seasoning extract;
[0017] c. Mix the sleep compound extract from step a and the seasoning extract from step b, add the remaining amount of liquor, let stand at 15-30°C for more than 1 month, and then filter to obtain the product.
[0018] Furthermore, the soaking liquid is circulated once a day during the 1st to 7th day of the soaking period, with each cycle lasting 15 minutes, and the soaking liquid is circulated once every three days on the remaining days, with each cycle lasting 10 to 30 minutes.
[0019] Furthermore, the two soaking times are 8 days, and the soaking liquid is circulated once a day during the 1st to 7th day of the soaking period, and each circulation time is 15 minutes.
[0020] Furthermore, the turbidity of the filtrate after filtration is ≤1.0.
[0021] Furthermore, the soaking time in step b is 25 days and the temperature is 20-30°C.
[0022] The health-care wine for improving sleep function of the present invention has a significant effect of improving sleep through specific medicinal flavors and dosage ratios. At the same time, through the use of specific seasoning raw materials and a specific preparation method, the health-care wine obtained by blending and aging has a high content of effective substances and a mellow taste, and has market promotion and application value.
[0023] Obviously, according to the above contents of the present invention, in accordance with common technical knowledge and customary means in the art, without departing from the above basic technical ideas of the present invention, other various forms of modification, replacement or change may be made.
[0024] The above contents of the present invention are further described in detail below through specific implementation methods in the form of embodiments. However, this should not be understood as the scope of the above subject matter of the present invention being limited to the following examples. All technologies realized based on the above contents of the present invention belong to the scope of the present invention. BRIEF DESCRIPTION OF THE DRAWINGS
[0025] Figure 1 This is the standard curve of oleanolic acid
[0026] Figure 2 This is the HPLC chromatogram of Schisandra chinensis
[0027] Figure 3 This is the standard curve of Schisandra ester A
[0028] Figure 4 This is the standard curve of Schisandrin A DETAILED DESCRIPTION
[0029] Example 1. Preparation of the health wine of the present invention
[0030] Recipe: 15kg of Schisandra chinensis, 15kg of Ganoderma lucidum, 12kg of Poria cocos, 6kg of Ophiopogon japonicus, 3kg of longan pulp, 2kg of Licorice, 2kg of Momordica grosvenori, 1000L of 40% vol liquor.
[0031] Preparation method:
[0032] (1) Slice Ganoderma lucidum, crush Schisandra chinensis, Poria cocos, and Radix Ophiopogonis into coarse powder, place the powder in an extraction container, and soak the medicinal materials twice in liquor with a concentration of 12 times and 10 times the total weight of the medicinal materials L / kg, each soaking temperature is 26°C, the soaking time is 10 days, and the soaking solution is circulated once a day from the 1st to the 7th day, and the soaking solution is circulated once on the 10th day, and the circulation time is 15 minutes;
[0033] After each extraction, the residue was separated from the extract by coarse filtration, the two extracts were combined, and the extract was filtered using a diatomaceous earth all-in-one machine. The turbidity of the extract after filtration was 0.7 NTU.
[0034] (2) taking longan pulp, adding 12 times the amount of L / kg of liquor to soak for extraction, soaking for 25 days; soaking at a temperature of 26° C., and obtaining a longan pulp extract after coarse filtration and fine filtration, the turbidity of the longan pulp extract was 0.7 NTU;
[0035] Take licorice, add 12 times the amount of L / kg of liquor to soak and extract, the soaking time is 25 days; the soaking temperature is 26°C, and after coarse filtration and fine filtration, a longan pulp extract is obtained, and the turbidity of the licorice extract is 0.9NTU;
[0036] Take the monk fruit, crush it, add 18 times the amount of L / kg of liquor to soak and extract, the soaking time is 25 days, the soaking temperature is 26°C, and the monk fruit extract is obtained through coarse filtration and fine filtration. The turbidity of the extract after filtration is required to be 0.9NTU;
[0037] (3) Since the sleep compound extract in step 1) and the longan pulp extract, licorice extract, and monk fruit extract in step 2 all have a 10-20% alcohol source loss during the preparation process, the total amount of the above extracts is less than 1000 L, so the above extracts are added to the remaining liquor and mixed to obtain a liquor with an alcohol content of 38% vol.
[0038] (4) The wine obtained in step 3) is aged at 5-30° C. for 1 month, and then filtered using a diatomaceous earth machine at a temperature of 15-30° C. to obtain the wine.
[0039] Example 2: Preparation of the health wine of the present invention
[0040] Formula: 15kg of Schisandra chinensis, 15kg of Ganoderma lucidum, 12g of Poria cocos, 6kg of Ophiopogon japonicus, and 1000L of 40% vol liquor.
[0041] Preparation method:
[0042] (1) Slice Ganoderma lucidum, crush South Schisandra chinensis, Poria cocos, and Radix Ophiopogonis into coarse powder, place the powder in an extraction container, add liquor 12 times and 10 times the total weight of the medicinal materials to soak the medicinal materials twice, each soaking temperature is 26° C., the time is 15 days, during which the soaking solution is circulated once a day from the 1st to the 7th day, each circulation time is 10 minutes, and the soaking solution is circulated every three days from the 8th to the 15th day, each circulation time is 15 minutes;
[0043] After each extraction, the residue was separated from the extract by coarse filtration, and finally the two extracts were combined and filtered using a diatomaceous earth all-in-one machine. The turbidity of the extract after filtration was 0.8 NTU.
[0044] (2) Since 10-20% of the alcohol source is lost during the preparation of the sleep compound extract in step 1), the total amount of the sleep compound extract is less than 1000 L. Therefore, the sleep compound extract in step 1) is supplemented with the remaining amount of liquor and mixed to obtain a liquor with an alcohol content of 38% vol.
[0045] (3) The extracted wine obtained in step 2) is aged at 5-30° C. for 1 month, and then filtered using a diatomaceous earth integrated machine at a temperature of 15-30° C. to obtain the obtained wine.
[0046] Example 3: Preparation of the health wine of the present invention
[0047] Formula: 12kg of Schisandra chinensis, 12kg of Ganoderma lucidum, 10kg of Poria cocos, 5kg of Ophiopogon japonicus, 800L of 40% vol liquor.
[0048] Preparation method:
[0049] (1) Slice Ganoderma lucidum, crush Schisandra chinensis, Poria cocos, and Radix Ophiopogonis into coarse powder, place the powder in an extraction container, and soak the medicinal materials twice with liquor 12 times and 10 times the total weight of the medicinal materials, each soaking temperature is 20° C., the time is 7 days, and the soaking liquid is circulated once a day, and the circulation time is 10 minutes each time;
[0050] After each extraction, the residue was separated from the extract by coarse filtration, and finally the two extracts were combined and filtered using a diatomaceous earth all-in-one machine. The turbidity of the extract after filtration was 0.9 NTU.
[0051] (2) Since 10-20% of the alcohol source is lost during the preparation of the sleep compound extract in step 1), the total amount of the sleep compound extract is less than 1000 L. Therefore, the sleep compound extract in step 1) is supplemented with the remaining amount of liquor and mixed to obtain a liquor with an alcohol content of 38% vol.
[0052] (3) The extracted wine obtained in step 2) is aged at 5-30° C. for 1 month, and then filtered using a diatomaceous earth integrated machine at a temperature of 15-30° C. to obtain the obtained wine.
[0053] Example 4: Preparation of the health wine of the present invention
[0054] Formula: 20kg of Schisandra chinensis, 20kg of Ganoderma lucidum, 18kg of Poria cocos, 12kg of Ophiopogon japonicus, and 1200L of 40% vol liquor.
[0055] Preparation method:
[0056] (1) Slice Ganoderma lucidum, crush South Schisandra chinensis, Poria cocos, and Radix Ophiopogonis into coarse powder, place the powder in an extraction container, add liquor 12 times and 10 times the total weight of the medicinal materials to soak the medicinal materials twice, each soaking temperature is 30° C., the time is 12 days, during which the soaking solution is circulated once a day from the 1st to the 7th day, each circulation time is 10 minutes, and the soaking solution is circulated every three days from the 8th to the 12th day, each circulation time is 15 minutes;
[0057] After each extraction, the residue was separated from the extract by coarse filtration. After the extraction, the two extracts were combined and filtered using a diatomaceous earth all-in-one machine. The turbidity of the extract after filtration was 0.9 NTU.
[0058] (2) Since 10-20% of the alcohol source is lost during the preparation of the sleep compound extract in step 1), the total amount of the sleep compound extract is less than 1000 L. Therefore, the sleep compound extract in step 1) is supplemented with the remaining amount of liquor and mixed to obtain a liquor with an alcohol content of 38% vol.
[0059] (3) The extracted wine obtained in step 2) is aged at 5-30° C. for 1 month, and then filtered using a diatomaceous earth integrated machine at a temperature of 15-30° C. to obtain the obtained wine.
[0060] Example 5: Preparation of the health wine of the present invention
[0061] Recipe: 12kg of Schisandra chinensis, 12kg of Ganoderma lucidum, 10kg of Poria cocos, 5kg of Ophiopogon japonicus, 1kg of Longan pulp, 1kg of Licorice root, 1kg of Momordica grosvenori, 800L of 40% vol liquor.
[0062] Preparation method: Same as Example 1
[0063] Example 6: Preparation of the health wine of the present invention
[0064] Formula: 15kg of Schisandra chinensis, 15kg of Ganoderma lucidum, 12kg of Poria cocos, 7g of Ophiopogon japonicus, 1kg of Longan pulp
[0065] G. 1kg licorice, 1kg monk fruit, 800L 40% vol liquor.
[0066] Preparation method: Same as Example 1
[0067] The beneficial effects of the present invention are described below through test examples.
[0068] Test Example 1 Determination of total saponin content of the health wine of the present invention
[0069] 1. Experimental Methods
[0070] (1) Preparation of reference solution Take an appropriate amount of oleanolic acid reference substance, weigh accurately, and add methanol to make a solution containing 0.20 mg per 1 mL.
[0071] (2) Preparation of standard curve: Accurately measure 0.1, 0.2, 0.3, 0.4, and 0.5 mL of the reference solution and place them in 15 mL stoppered test tubes, evaporate to dryness, cool, accurately add 0.2 mL of freshly prepared 5% vanillin glacial acetic acid solution and 0.8 mL of perchloric acid, shake well, heat in a 70°C water bath for 15 min, immediately cool in an ice bath for 5 min, take out, accurately add 4 mL of ethyl acetate, shake well, use the corresponding reagent as blank, measure the absorbance at a wavelength of 546 nm, and draw a standard curve with the absorbance as the ordinate and the concentration as the abscissa. See the standard curve of total saponins for details. Figure 1 .
[0072] (3) Preparation of test solution Take 100 mL of three batches of health wine prepared in Example 1 (2019081901, 2019081902, and 2019081903), recover the solvent (-0.065 to -0.095 MPa, 65°C) and concentrate it to an extract with a relative density of 1.30 to 1.35 (60°C), transfer the extract to a porcelain evaporating dish, evaporate to dryness on a 60°C water bath, add 10 mL of anhydrous ethanol to dissolve, filter, and place the filtrate in a 100 mL volumetric flask. Use appropriate amount of ethanol to wash the filter and filter residue in several times, combine the washing liquid into the same volumetric flask, add ethanol to the scale, shake well, and obtain.
[0073] (4) Content determination: Accurately measure 0.2 mL of the sample solution and place it in a 15 mL stoppered test tube. Following the method under "(2)", measure the absorbance starting from "evaporation to dryness" and read the oleanolic acid content in the sample solution from the standard curve. Calculate the sample content.
[0074] 2. Experimental results
[0075] (1) The regression equation is calculated as Y = 8.3155X, R 2 =0.9999. The results showed that the absorbance value and total saponin content had a good linear relationship in the concentration range of 0.004-0.02 mg / mL.
[0076] (2) The above method was used to determine the total saponin content in three batches of wine samples. The experimental results are shown in Table 1, indicating that the total saponin content of the health wine was high.
[0077] Table 1 Detection results of the content of various index components of a sleep-improving health wine
[0078]
[0079] Test Example 2 Determination of lignan content in the health wine of the present invention
[0080] Schisandrae Chinensis is the main drug in the compound for improving sleep. In the 2015 edition of the Chinese Pharmacopoeia, schisandrae ester A is used as the content determination component. Literature studies have shown that the content of schisandrae ester A and schisandrin in Schisandrae Chinensis is relatively high, and it is an important active ingredient of Schisandrae Chinensis that improves sleep. Therefore, the present invention refers to the literature reports in recent years to use high performance liquid chromatography (HPLC) to determine the lignan components in the product to control the product quality, wherein the lignan content is measured by schisandrae ester A and schisandrin A content.
[0081] 1. Experimental Methods
[0082] (1) Chromatographic conditions: Chromatographic column: Athena C18-WP 4.6*150 mm, 3 μm (LAEQ-462572); Mobile phase: Gradient elution of mobile phase acetonitrile (A)-water solution (B) (0-25 min, 50%-80% A); Flow rate: 1.0 mL / min; Column temperature: 40°C; Detection wavelength: 220 nm. The number of theoretical plates is not less than 3000.
[0083] (2) Preparation of reference solution: 20.0 mg of schisandrin A and schisandrin A standard were accurately weighed and made up to 25 mL volumetric flask with chromatographic methanol to prepare standard stock solutions for later use.
[0084] (3) Preparation of the test solution 200 mL of the health wine prepared in Example 1 was measured, the solvent (-0.065 to -0.095 MPa, 65°C) was recovered and concentrated to an extract with a relative density of 1.30 to 1.35 (60°C), the extract was transferred to a porcelain evaporating dish, evaporated to dryness on a 60°C water bath, 2 mL of methanol was added to dissolve, filtered, the filtrate was placed in a 5 mL volumetric bottle, and the filter and filter residue were washed with an appropriate amount of methanol in several times, the washing liquid was added to the same volumetric bottle, methanol was added to the scale, the filtrate was taken, centrifuged at 4000 r / min for 10 min, and the supernatant was taken for solid phase extraction pretreatment (SPE). The specific treatment process is: the SPE column is activated with 6 mL of methanol, and then balanced with 6 mL of 50% methanol aqueous solution. After the SPE column is balanced, 1 mL of the test solution is accurately drawn onto the column, and the column is washed with 6 mL of deionized water. Then, 10 mL of methanol was used for elution, and the eluate was filtered through a 0.22 μm filter membrane to obtain the product.
[0085] (4) Preparation of negative control sample solution A negative control solution of the health wine extract (i.e., a blank control sample prepared according to the health wine prescription ratio and the same preparation process but without Schisandrae Chinensis slices) was prepared according to the preparation method of the test sample solution under "(3)" to prepare a negative control sample solution.
[0086] (5) Content Determination According to the chromatographic conditions under "(1)", 10 μL of the mixed standard solution and the test solution were respectively injected into the liquid chromatograph, and the peak areas of schisandrin A and schisandrin A were determined according to the chromatographic conditions. Each sample was measured three times, and the average contents of schisandrin A and schisandrin A in the samples were calculated according to the linear regression equation.
[0087] 2. Experimental results
[0088] (1) System suitability test and specificity test
[0089] Accurately pipette 10 μL of schisandrin A mixed reference solution, test solution and compound negative reference solution into the liquid chromatograph and record the chromatogram. Figure 2As shown, the retention time of schisandrin A is about 15.994min, and the retention time of schisandrin A is about 22.147min; the separation between schisandrin A and adjacent chromatographic peaks is good (R>1.5), the peak symmetry is good, and the theoretical plate numbers are 18395 and 18185, respectively; and the negative control solution of the health wine compound has no interference with the quantitative determination of the test sample.
[0090] (2) Establishment of standard curves for schisandrin A and schisandrin A
[0091] The reference solutions of schisandra chinensis ester A and schisandra chinensis glycoside A were diluted with chromatographic methanol to form a series of reference solutions with contents of 400, 200, 100, 50, 25, and 10 ug / mL, filtered using a 0.22 μm microporous filter membrane, and sequentially entered into a high performance liquid chromatograph for determination according to the chromatographic conditions under the experimental method "(2)", and the peak areas of schisandra chinensis ester A and schisandra chinensis glycoside A were recorded. A standard curve was drawn with the peak area as the ordinate (Y) and the reference solution concentration C (μg / mL) as the abscissa (X), and the linear regression equations of schisandra chinensis ester A and schisandra chinensis glycoside A were obtained. Figure 3 , Figure 4 As shown, the linear regression equation of schisandrin A is Y=51184X (R2=0.9999, n=6), and the linear regression equation of schisandrin A is Y=6.3417X (R2=0.9998, n=6). The results show that schisandrin A and schisandrin A have a good linear relationship in the concentration range of 10-400 μg / mL.
[0092] (3) Precision test Take 10uL of the mixed reference solution of schisandra ester A and schisandra chinensis A under "Experimental method (2)" and measure according to the chromatographic conditions under "Experimental method (1)". Measure 6 times in succession, record the peak area, and calculate the RSD. The results show that the RSD of schisandra ester A is 0.10%, and the RSD of schisandra chinensis A is 0.07%, indicating that the instrument has good precision.
[0093] (4) Repeatability test Take the same extract sample to be tested, a total of 6 parts, and prepare the test solution according to the method under "2.1.3". Determine according to the chromatographic conditions under "Experimental method (1)", record the peak area, and calculate the mass fraction of schisandrin ester A and schisandrin A. Results The average mass fraction of schisandrin ester A and schisandrin A in the extract was 10.77 mg / mL, with an RSD of 2.72%; the average mass fraction of schisandrin A was 13.61 mg / mL, with an RSD of 2.58%, indicating that the method has good repeatability.
[0094] (5) Stability test The same test sample solution was taken and placed for 0, 2, 4, 8, 12, and 24 hours, and then the sample was analyzed and the peak area was recorded. The contents of schisandrin A and schisandrin A were calculated to determine the stability of the test sample solution. The results showed that the RSD of the peak area of schisandrin A and schisandrin A within 24 hours were 0.28% and 0.33%, respectively. From the results in Table 2-8, it can be seen that the test sample solution has good stability within 24 hours.
[0095] (6) Sample recovery test Weigh an appropriate amount of the reference substance and add it to the same batch of samples with known contents (the contents of schisandrin A and schisandrin A in the known samples are 22.81 mg / g and 27.34 mg / g, respectively). Prepare the test solution according to the method under "Experimental method (3)". Perform the test analysis according to the chromatographic conditions under "Experimental method (1)". Record the peak area and calculate the sample recovery. Results The average sample recovery of schisandrin A and schisandrin A was 98.97% and 99.25%, respectively, indicating that this determination method meets the analytical requirements. The results are shown in Table 2.
[0096] Table 2 Recovery test of schisandrin A and schisandrin A (n=6)
[0097]
[0098] (7) Test results of health wine with sleep-improving function
[0099] The contents of schisandrin A, schisandrin A and lignans in three batches of the health wine of the present invention (2019081901, 2019081902, and 2019081903) were determined as shown in Table 3.
[0100] Table 3 Test results of the content of various index components of health wine for improving sleep function
[0101]
[0102] Test Example 3 Taste Test of the Health Wine of the Present Invention
[0103] 1. Methods
[0104] The sensory evaluation team of this test consists of 6 people, including 4 national wine judges and 2 professional wine tasters. The sensory evaluation team will evaluate the sensory quality of the health wine.
[0105] The test adopts a secret evaluation method, referring to the national standard for sensory analysis (GB / T 33406-2016) and the national standard for liquor (GBT27588-2011). Professional judges secretly number the wine samples, which are randomly presented for evaluation after coding. The wine tasting glasses are the special liquor tasting glasses (with cup feet) specified in GB / T 33406-2016, and about 20mL of wine is poured into each glass.
[0106] The wine samples were uniformly managed by the coding personnel, and the evaluation team conducted sensory evaluation in a well-ventilated, brightly lit and quiet professional wine tasting room. The evaluation time lasted for 40 minutes. As many descriptive words as possible were written from the aspects of the aroma and taste of the health wine, and the health wines with different ratios of seasoning raw materials prepared in Example 1 were sensory evaluated.
[0107] 2. Results
[0108] The specific results are shown in Table 4
[0109] Table 4 Sensory evaluation results of different health wines
[0110]
[0111]
[0112] As shown in Table 4, with the increase of seasoning liquid, the bitterness of health wine weakens, the sweetness increases, but the natural sweetness gradually decreases; at the same time, when the amount of monk fruit and licorice added increases, the aroma coordination of health wine decreases, the astringency increases, and the body of the wine becomes rough. Therefore, the amount of monk fruit and licorice is selected to be 0.1% to 0.3% as the production range. The increase in the amount of longan meat added will increase the sweetness and improve the thickness of the wine, but from the perspective of product storage stability, the addition amount should not exceed 0.5%, so the longan meat range is selected to be 0.1% to 0.5% as the production range.
[0113] That is, through the taste test, it is determined that the amount of seasoning raw materials in every 100L of health wine is 0.1-0.5kg of longan pulp, 0.1-0.3kg of monk fruit, and 0.1-0.3kg of monk fruit.
[0114] Test Example 4 Study on the tranquilizing effect of the health wine of the present invention
[0115] According to the evaluation standard of "improving sleep function" in the "Technical Specifications for Inspection and Evaluation of Health Food", the health wine sample prepared in Example 1 was taken to evaluate the sleep improvement effect.
[0116] 1. Experimental Methods
[0117] ① Dosage grouping and test sample administration time
[0118] Three experimental groups were set up for the experimental animals, namely, a normal control group, a health wine sample group (the health wine prepared in Example 1), and a health wine prescription water extraction control group (the raw material water extract after removing the liquor in Example 1). The gavage dose was 30 times the recommended amount for the human body, the health wine sample was treated to recover ethanol, and the volume was fixed with 0.5% CMC-Na as a solvent, the health wine prescription water extraction control group, after the water extraction was concentrated according to the dosage prescription, the volume was fixed with 0.5% CMC-Na as a solvent, and the normal control group was gavaged with 0.5% CMC-Na, once a day, for 30 consecutive days.
[0119] ②Effects on spontaneous activity of mice
[0120] Half an hour after the last administration, the mouse autonomous activity test was conducted. The mice in each group were placed in the autonomous activity tester in the order of number, and the autonomous activity of the mice was recorded. Each test lasted 15 minutes, and the number of mouse activities in the last 10 minutes was counted.
[0121] ③Direct sleep experiment
[0122] Observe whether the animals in the test group fall asleep after being given the test sample and the control group is given the same volume of solvent. The disappearance of the righting reflex is used as an indicator of sleep. When the mouse is placed in a dorsal recumbent position, it can turn right immediately. If it cannot turn right for more than 30-60 seconds, it is considered that the righting reflex has disappeared and it has fallen asleep. The recovery of the righting reflex means that the animal has awakened, and the time from the disappearance of the righting reflex to the recovery is the animal's sleep time. Record the number of sleeping animals and the sleep time in the blank control group and the test sample group.
[0123] ④ Experiment on prolonging sleep time with sodium pentobarbital
[0124] On the basis of sodium pentobarbital hypnosis, observe whether the test substance can prolong sleep time. If sleep time is prolonged, it means that the test substance and sodium pentobarbital have a synergistic effect.
[0125] Before the formal experiment, a preliminary experiment was conducted to determine the dose of sodium pentobarbital (30-60 mg / kg) that would make the animals fall asleep 100% but not make them sleep too long. This dose was used in the formal experiment.
[0126] After the last administration of solvent and different test samples to each group of mice, each group of animals was intraperitoneally injected with sodium pentobarbital 10-15 minutes before the peak effect appeared. The injection volume was 0.1ml / 10g. The disappearance of righting reflex was used as an indicator to observe whether the test samples could prolong the sleeping time of sodium pentobarbital.
[0127] The experimental data were analyzed by variance analysis.
[0128] ⑤ Subthreshold dose hypnosis experiment of sodium pentobarbital
[0129] Observe the synergistic effect of the test substance and sodium pentobarbital. Before the formal experiment, a preliminary experiment was conducted to determine the subthreshold hypnotic dose of sodium pentobarbital (16-30 mg / kg), that is, the maximum subthreshold dose of sodium pentobarbital at which the righting reflex of 80-90% of mice does not disappear. After the animals were last given the solvent and different test samples, 10-15 minutes before the peak effect appeared, each group of animals was intraperitoneally injected with the maximum subthreshold hypnotic dose of sodium pentobarbital, and the number of animals that fell asleep within 30 minutes (those with righting reflex disappearance for more than 1 minute) was recorded.
[0130] The number of animals that fell asleep was compared using the chi-square test.
[0131] 2. Experimental results
[0132] ①Effects on spontaneous activity of mice
[0133] There was no significant difference in the spontaneous activity of mice between the test sample groups and the normal control group (P>0.05), indicating that the test samples had no effect on the spontaneous activity of mice. The experimental results are shown in Table 5.
[0134] Table 5 Effects on spontaneous activity of mice
[0135]
[0136] ② Effects on the direct sleep of mice
[0137] The test samples used in the experiment did not directly cause the mice to sleep, indicating that the test samples did not have a central nervous system inhibitory effect that could directly cause the mice to sleep at the experimental dose.
[0138] ③The effect of sodium pentobarbital on prolonging sleep time
[0139] For the sleep of mice induced by sodium pentobarbital (above threshold dose), the health wine samples can significantly shorten the sleep latency of mice and significantly prolong the sleep time of mice (P<0.05). The experimental results are shown in Table 6.
[0140] Table 6 Effect of prolonging sleep time with sodium pentobarbital
[0141]
[0142] Note: Compared with the normal control group, *P<0.05.
[0143] ④Effects on the subthreshold dose hypnotic experiment of sodium pentobarbital in mice
[0144] The health wine sample has the effect of significantly increasing the number of sleeping mice at a subthreshold dose of sodium pentobarbital (P<0.01). The experimental results are shown in Table 7.
[0145] Table 7 Effects of the extract on the subthreshold dose hypnotic test of sodium pentobarbital in mice
[0146]
[0147] Note: Compared with the normal control group, *P<0.05.
[0148] From the above experimental results, it can be seen that after mice were gavaged with different samples at a dose of 30 times the recommended human dosage for 30 consecutive days, no direct sleep phenomenon occurred. Compared with the solvent control group, there was no significant difference in the number of autonomous activities of mice in different samples (P>0.05); the health wine samples can prolong the sleep time (P<0.05) and shorten the sleep latency of mice (P<0.05). It can be seen that the health wine samples obtained by the present invention have a certain effect of improving sleep.
[0149] In summary, the health wine with sleep improving function of the present invention adopts the leaching process to extract the flavor and functional components in the raw materials, has the characteristics of simple preparation process and clear functional components, has the advantages of appropriate medicinal aroma of health wine, moderate sourness and sweetness, mellow and coordinated taste, and has the effects of calming the mind and improving sleep.
Claims
1. A health wine for improving sleep function, characterized in that: It is prepared from raw materials in the following proportions: 15 parts by weight of Schisandra chinensis, 15 parts by weight of Ganoderma lucidum, 12 parts by weight of Poria cocos, 6 parts by weight of Ophiopogon japonicus, 3 parts by weight of Longan pulp, 2 parts by weight of Licorice, 2 parts by weight of Momordica grosvenori, and 1000 parts by volume of liquor; The preparation method of the health wine comprises the following steps: a. Take sliced Ganoderma lucidum, crushed Schisandra chinensis, Poria cocos and Radix Ophiopogonis, mix them, soak them twice with liquor, the amount of liquor used twice is 12 to 15 times the amount v / w, ml / g, and 8 to 11 times the amount v / w, ml / g of the raw materials respectively, the soaking time is 7 to 15 days, the soaking liquid is circulated during the soaking period, and after the soaking, the filtrate is filtered and the filtrate is combined to obtain the sleep compound extraction stock solution; b. Take longan pulp, licorice and monk fruit respectively, soak them in liquor (12 to 15 times the amount v / w, ml / g) of the raw materials, filter and obtain seasoning extract; c. Mix the sleep compound extract from step a and the seasoning extract from step b, add the remaining amount of liquor, let stand at 15-30°C for more than 1 month, and then filter to obtain the product.
2. The health wine according to claim 1, characterized in that: The alcohol content of the liquor is 30-60%.
3. The health wine according to claim 1, characterized in that: The two soaking times in step a are 8 days, and the soaking liquid is circulated once a day during the 1-7 days of the soaking period, and each circulation time is 15 minutes.
4. The health wine according to claim 1, characterized in that: The turbidity of the filtrate after filtration is ≤1.
0.
5. The health wine according to claim 1, characterized in that: The soaking time in step b is 25 days at a temperature of 20-30°C.
